Pharma Stock Roundup: AZN"s Leukemia Drug Wins FDA Nod, MRK"s Keytruda in Focus

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 3.) Acceleron Pharma Inc (NASDAQ: XLRN) Aptose Biosciences .....»»

Vertex Pharmaceuticals Inc. shares rose in the extended session Thursday after the biotech drug maker's results and forecast topped Wall Street estimates. Vertex shares rose 2.9% after .....»»

Acceleron Pharma Inc. shares surged in the extended session late Monday after the biotech drug maker said its hypertension drug hit key goals in a mid-stage clinical trial. Acceleron shares soared 56%.....»»

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

It's a wonder that Ontario-based Aphria survived 2019 at all. Now that it has, what can investors look forward to in 2020?.....»»

Xeris Pharmaceuticals Inc. shares rallied in the extended session Monday after the drug maker said its diabetes treatment showed positive results in a .....»»

Merck & Co. shares slipped in the extended session Monday after the drug maker said that its lung-cancer drug Keytruda did not meet one of its endpoints in a clinical study. Merck shares declined 0......»»

The following is a roundup of top developments in the biotech space over the last 24 hours.  Scaling The Peaks (Biotech stocks that hit 52-week highs on Dec. 31.) 0 read more.....»»

Shares of microcap Correvio Pharma Corp. slid about 12% in premarket trade Tuesday, after the company said it has received a Complete Response Letter from the U.S. Food and Drug Ad.....»»

The Food and Drug Administration on Wednesday approved Padcev as a treatment for metastatic urothelial cancer. The therapy is jointly being developed by Astellas Pharma Inc.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 18) 10X Genomics Inc (NASDAQ: TXG) Acceleron.....»»

Reata Pharmaceuticals Inc. shares were halted in the extended session Monday as the biotech drug developer reported positive results from a late-stage kidney disease treatment study. Reata shares were flat, following a .....»»

Shares of GW Pharmaceuticals PLC sunk more than 12% in the extended session Tuesday, after the cannabinoid drug maker reported better-than-expected revenue from its flagship product, Epidiolex......»»

The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Sept. 23.) read more.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 6) Allakos Inc (NASDAQ: ALLK)(announced common stock offering) Cytokinetics, Inc. (NASDAQ: CYTK) Ins.....»»

GW Pharmaceuticals PLC reported Tuesday afternoon that sales of its cannabis-derived epilepsy drug more than doubled from the previous quarter, sending shares spiking more than 11% higher in after-hours trading......»»

Take-Two Interactive Software, Inc (NASDAQ: TTWO) stock was soaring Tuesday as analysts boosted price estimates in the wake of another big earnings beat and guidance that suggests the company thinks more wins.....»»

With key drugs losing exclusivity, key drug makers are poised to face deep trouble since their sales are mostly dependent on a single drug. Want the latest recommendations from Zacks Investment Research? Today, you can download 7.....»»

Zacks.....»»

Thinly traded nano-cap biotech Cytori Therapeutics Inc (NASDAQ: CYTX), which has been trading in penny stock territory for about a year now, could see some activity in the wake of a company announcement Friday.  read more.....»»